Drug profile · INN
isosorbide mononitrate
APO-ISOSORBIDE MONONITRATE
isosorbide mononitrate (APO-ISOSORBIDE MONONITRATE) is a soluble guanylate cyclase activator. Associated with Alphapharm Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
Drug details — isosorbide mononitrate
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 2
- Programs
- 1
- Data quality
- 0.89
Quick answer
isosorbide mononitrate (APO-ISOSORBIDE MONONITRATE) is a soluble guanylate cyclase activator. Associated with Alphapharm Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Soluble guanylate cyclase activator
Primary target: Soluble guanylate cyclase
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| TGA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
Frequently asked questions
What is isosorbide mononitrate?
isosorbide mononitrate (APO-ISOSORBIDE MONONITRATE) is a soluble guanylate cyclase activator. Associated with Alphapharm Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for isosorbide mononitrate?
APO-ISOSORBIDE MONONITRATE is a marketed brand name for isosorbide mononitrate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of isosorbide mononitrate?
isosorbide mononitrate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.